Mycoplasmosis (M. gallisepticum)

Impact of Mycoplasma gallisepticum (MG) infection

Mycoplasma gallisepticum (MG) is a major respiratory disease to poultry species (chickens and turkeys) worldwide with a huge economic impact. 

The disease is transmitted both horizontally and vertically and both young and mature birds are susceptible, and once a flock is infected, the flock is infected for life. 

  • Birds infected with MG show airsacculitis, reduced weight gain and feed efficiency. 
  • The egg production losses can be severe (up to 16 eggs per hen) and secondary infections can cause mortality. 
  • Flocks infected with MG are more susceptible to other diseases such as IBV, NDV, Infectious Coryza and Escherichia coli.

Vaccination: an important tool to control MG

Vectormune® FP-MG and Vectormune® FP-MG + AE were developed by CEVA Santé Animale using the most advanced molecular technology to bring to the poultry industry a novel broad-spectrum vaccine that provides efficacy, safety and convenience in the control of  Mycoplasma gallisepticum, Fowl Pox and Avian Encephalomyelitis.